Pharmacokinetics and biological responses after treatment of the rat R-1 rhabdomyosarcoma with methotrexate
β Scribed by J. B. A. Kipp; A. Leyva; A. H. Van Gennip; H. B. Kal
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- French
- Weight
- 850 KB
- Volume
- 54
- Category
- Article
- ISSN
- 0020-7136
No coin nor oath required. For personal study only.
β¦ Synopsis
Time relationships of drug concentrations in tissue of a transplantable rat rhabdomyosarcoma and of tumour responses up to I20 hr after treatment with methotrexate (MTX) were analysed and compared. MTX was shown to be retained within the tumour in a substantial concentration for several days, although no evidence of MTX polyglutamation was obtained. The response data confirm that MTX is active in the tumour for up to at least 3 days after injection. Within the first day after MTX treatment the nucleotide pools are only partly depleted. This indicates that the inhibition of DNA synthesis is still incomplete at the time when salvage precursors in increasing amounts are becoming available from decaying cells. From flow cytometric analysis of cell-cycle progression it is concluded that subsequent cohorts arriving in early S-phase were retarded, but not inhibited, in their progression through the S phase. At 3 days after MTX treatment the mean rate of cell-cycle progression as well as the relative clonogenic capacity were maximally reduced to 30% and I 'Yo of control values, respectively. From 3 to 5 days the rate of cell-cycle progression was gradually restored, whereas from day 5 onwards the clonogenic capacity
π SIMILAR VOLUMES
Convulsions from combined pinealectomy and parathyroidectomy were examined in rats treated as neonates with 6-hydroxydopamine (6-OHDA). Injection of 6-OHDA caused a significant reduction in the average latency to onset of clonictonic convulsions. Moreover, of the 6-OHDA-treated rats which convulsed,
## Abstract ## Objective To examine the roles of specific genetic polymorphisms as predictors of response to treatment of early rheumatoid arthritis (RA). ## Methods Subjects included 457 patients with early RA (duration of β€3 years) who participated in a randomized controlled trial comparing we